An implication of hypertriglyceridemia in the progression of diabetic nephropathy in metabolically obese, normal weight patients with type 2 diabetes mellitus in Korea-Reference-Cited by-同舟云学术

An implication of hypertriglyceridemia in the progression of diabetic nephropathy in metabolically obese, normal weight patients with type 2 diabetes mellitus in Korea

Published:2004-12 Issue: Volume:66 Page:S169-S172
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Kim D.M.,Ahn C.W.,Park J.S.,Cha B.S.,Lim S.K.,Kim K.R.,Lee H.C.,Huh K.B.

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference10 articles.

1. The natural history of diabetic nephropathy;Selby;JAMA,1990

2. Role of hyperlipidemia in progressive renal disease: focus on diabetic nephropathy;Jandeleit-Dahm;Kidney Int.,1999

3. Potential role of lipids in the progression of diabetic nephropathy;Kramer-Guth;Clin. Nephrol.,1996

4. The effect of metabolic control on development and progression of diabetic nephropathy;Di Landro;Nephrol. Dial. Transplant.,1998

5. Glycated hemoglobin and risk of microalbuminuria in patients with insulin-dependent diabetes mellitus;Krolewski;N. Engl. J. Med.,1995

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Severe Hypertriglyceridemia in Patients with Type 2 Diabetes Mellitus Participating in the AMD Annals Initiative;Metabolic Syndrome and Related Disorders;2024-08-01

2. Association of urinary albumin-to-creatinine ratio with lipid abnormalities and glycemic control in patients with type 2 diabetes mellitus;Annals of Medicine & Surgery;2023-07-19

3. The nature and characteristics of hypertriglyceridemia in a large cohort with type 2 diabetes;Journal of Diabetes and its Complications;2023-02

4. Risk factors for subclinical renal damage and its progression: Hanzhong Adolescent Hypertension Study;European Journal of Clinical Nutrition;2020-09-29

5. Effects of glucose-lowering agents on surrogate endpoints and hard clinical renal outcomes in patients with type 2 diabetes;Diabetes & Metabolism;2019-04